Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective for this study is to evaluate the efficacy of MPDL3280A compared with carboplatin or cisplatin + gemcitabine in chemotherapy-naive patients with Stage IV squamous NSCLC, as measured by investigator-assessed PFS according to RECIST v1.1
Critère d'inclusion
- Previously untreated Stage IV, Squamous, Non-Small Cell Lung Cancer